- Home
- ORGO vs BLW Comparison
ORGO vs BLW Comparison
Compare ORGO & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- BLW
- Stock Information
- Founded
- ORGO 1985
- BLW 2003
- Country
- ORGO United States
- BLW United States
- Employees
- ORGO N/A
- BLW N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- BLW Other Consumer Services
- Sector
- ORGO Health Care
- BLW Consumer Discretionary
- Exchange
- ORGO Nasdaq
- BLW Nasdaq
- Market Cap
- ORGO 533.9M
- BLW 518.5M
- IPO Year
- ORGO N/A
- BLW N/A
- Fundamental
- Price
- ORGO $3.11
- BLW $14.03
- Analyst Decision
- ORGO Buy
- BLW
- Analyst Count
- ORGO 2
- BLW 0
- Target Price
- ORGO $5.50
- BLW N/A
- AVG Volume (30 Days)
- ORGO 2.1M
- BLW 85.9K
- Earning Date
- ORGO 05-08-2025
- BLW 01-01-0001
- Dividend Yield
- ORGO N/A
- BLW 8.83%
- EPS Growth
- ORGO N/A
- BLW N/A
- EPS
- ORGO N/A
- BLW 1.81
- Revenue
- ORGO $458,760,000.00
- BLW N/A
- Revenue This Year
- ORGO $3.31
- BLW N/A
- Revenue Next Year
- ORGO $12.50
- BLW N/A
- P/E Ratio
- ORGO N/A
- BLW $7.73
- Revenue Growth
- ORGO 5.35
- BLW N/A
- 52 Week Low
- ORGO $2.17
- BLW $12.35
- 52 Week High
- ORGO $6.71
- BLW $14.26
- Technical
- Relative Strength Index (RSI)
- ORGO 31.37
- BLW 64.51
- Support Level
- ORGO $2.88
- BLW $13.82
- Resistance Level
- ORGO $5.55
- BLW $13.76
- Average True Range (ATR)
- ORGO 0.39
- BLW 0.11
- MACD
- ORGO -0.23
- BLW 0.05
- Stochastic Oscillator
- ORGO 7.68
- BLW 95.45
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.